India BIRAC Biotechnology Ignition Grant

India BIRAC Biotechnology Ignition Grant (BIG)

Historical reference: BIRAC’s latest listed BIG round, the 25th call, closed on 2025-11-30. No later BIG call was announced on the official BIRAC call page checked for this update. Do not treat this page as an open application window; use the official program page to watch for a new call.

The Biotechnology Ignition Grant (BIG) is BIRAC’s early-stage grant for Indian biotech companies and LLPs that need to move an innovative idea toward proof of concept. It is designed for a project with a credible technical question, a defined commercial or societal need, and a work plan that can be executed with a grant of up to INR 50 lakhs over up to 18 months. It is not a general operating subsidy, a research fellowship, or a replacement for later clinical, field, certification, or scale-up finance.

This entry describes the latest listed round and the standing scheme rules in BIRAC’s current BIG guidance. The date in the front matter is intentionally the real closing date of that closed round. The historical flag prevents the page from presenting an expired deadline as if applicants could still submit. BIRAC’s main BIG page continues to describe the scheme and links to the 25th call, guidelines, proposal materials, and registration information. A future call may change its documents, partners, dates, or eligibility details, so applicants must read the new call notice rather than reuse this page as an application form.

At a glance

What BIG is intended to fund

BIRAC describes BIG as a scheme for innovative ideas with commercialisation potential. The current guidance lists seven broad proposal categories: devices and diagnostics; drugs, including drug delivery; industrial biotechnology including secondary agriculture; agriculture; biosimilars and stem cells; vaccines; and bioinformatics. The guidance also allows biotech proposals that integrate applied disciplines such as engineering, artificial intelligence, sensors, automation, or robotics when that integration helps address a biotech, health, agriculture, or bio-based industry need.

The important boundary is project stage. BIG supports work from ideation to proof of concept. A proposal should explain what is already known, what remains uncertain, which experiment or prototype will resolve that uncertainty, and what evidence will count as success. The grant is a poor fit for basic or exploratory research without a path toward a product or technology. It is also a poor fit for a late-stage program centered on systematic clinical trials, field trials, or final validation and certification. Those exclusions matter because a technically impressive project can still be at the wrong stage for this scheme.

The official purpose is broader than paying for laboratory inputs. BIRAC aims to foster ideas with commercialisation potential, validate proof of concept, encourage researchers to take technology closer to market through a startup, and stimulate enterprise formation. A strong proposal therefore connects its technical work to an unmet need, an identifiable user or market, and a credible route to the next stage of development.

Funding and project design

The maximum support is INR 50 lakhs in grant-in-aid for a project lasting up to 18 months. Funding is milestone based rather than an unrestricted payment. The current guidance describes three to four installments: INR 20 lakhs after signing the grant agreement; one or two further installments of up to INR 20 lakhs each, released against satisfactory progress and funding need; and up to INR 5 lakhs after successful completion and submission of the final technical report. The total cannot exceed INR 50 lakhs. The final tranche is reimbursement after acceptance of the final Utilization Certificate, Statement of Expenditure, and Project Completion Report.

That structure should shape the proposal from the beginning. Divide the project into a small number of measurable milestones, and connect every major budget item to one of them. A sensible plan might start by confirming feasibility and locking the experimental method, then move through prototype or assay development, repeatability testing, and a final proof-of-concept package. The exact sequence depends on the technology; BIRAC does not promise that every project follows the same scientific timetable.

The guidance identifies recurring budget heads such as manpower, consumables, incubation space and services, travel, intellectual-property costs, outsourcing, contingency, and other operating costs. Equipment is treated as a non-recurring expense. Applicants should justify why each expense is necessary for the next milestone and keep quotations, facility arrangements, and supplier information ready for later checks. A budget that spends most of the award on broad overheads without a clear validation result is difficult to defend under a milestone-linked grant.

BIG also provides entrepreneurial support through BIRAC and its BIG Partners. The listed forms of support include technical mentoring, IP and legal support, networking, training, regulatory advice, business mentoring, and investor connections. This support does not turn an unready proposal into an eligible one. It is most useful when the team can state its technical gaps, identify the decisions that need outside advice, and show how mentoring will change the project plan.

Eligibility for the current guidance

The current BIG guidance is more specific than the older summary on this page. The applicant must be a company or LLP registered under the Indian Companies Act 1956/2013. The incorporation date must be no earlier than five years before the launch of the particular BIG call. Because the age test is tied to the call, a future round must be checked independently rather than inferred from the closed-round date.

The company must meet BIRAC’s resident-ownership condition: at least 51% of its capital must be beneficially owned by resident Indian citizens and/or Indian companies that are ultimately owned and controlled by resident Indian citizens. The guidance states that NRIs are Indian citizens for this scheme, while OCI and PIO cardholders are not eligible under its definition of Indian citizen. Ownership should be documented clearly; an informal description of the cap table is not a substitute for the records requested during verification.

Every proposal must name a Project Leader. That person is responsible for the technical and managerial execution of the project, must be technically qualified, and must have completed basic undergraduate training in any discipline. For a company applicant, the Project Leader must also be a shareholder. If the proposal reaches presentation, the Project Leader is expected to present it, and a funded Project Leader signs the project agreement.

The applicant must have a functional and adequate in-house R&D facility for the proposed work. If it does not, the company must be incubated at an incubator; the BIG Partner verifies and confirms that arrangement. The proposal should therefore identify the actual lab, equipment, samples, manufacturing access, or specialist service needed. A generic statement that the team can find a facility later leaves a material eligibility and execution risk.

The guidance also excludes an applicant company when a promoter holding at least 20% is a co-promoter of another ineligible company or a partner in another ineligible LLP, except for the stated non-biotech-domain exception. Companies and promoters in default on loan repayment to BIRAC are ineligible. The proposed objectives and deliverables must not already have received support from another agency, and the guidance says BIG support can be provided only once to any startup. These are checks to perform before writing the narrative, not details to discover after submission.

What to prepare before a future call

Start with a one-page fit check. State the unmet need, the proposed product or technology, its current evidence, the proof-of-concept result needed next, and the commercial or societal use if that result is achieved. Make the project narrow enough to complete within the permitted period and funding cap. If the work requires a full clinical program, a broad field rollout, or final certification, it may need a different BIRAC scheme or a later financing stage.

Then assemble the legal and operational evidence. Keep the certificate of incorporation, LLP or company details, cap table, resident-ownership evidence, and promoter information consistent. Identify the Project Leader and make the shareholding requirement explicit. Secure an in-house facility description or a letter of interest or intent from the incubator. If execution depends on a unique facility, key sample, manufacturer, or supplier, obtain evidence of access rather than listing an unconfirmed plan.

The current guidance expects several documents for verification before the Technical Expert Panel. These include undertakings from scientific advisors or mentors, undertakings from key technical team members, an incubator letter of interest or intent, evidence of access to unique facilities, and evidence of access to key samples such as bio-fluids when relevant. After results, the BIG Partner may require an incubator acceptance letter or memorandum of understanding, formal agreements with facility providers or suppliers, and case-specific due-diligence documents such as technology-licensing records, IP clarification, or a no-objection certificate from an institute.

Prepare a proposal that a technical reviewer can test. Describe the method, controls, measurements, expected outputs, risks, fallback route, and the evidence that separates a successful milestone from an inconclusive one. Include the commercial perspective: target users, competing or alternative solutions, differentiation, adoption route, regulatory questions, and the next funding or partnership step. BIRAC’s evaluation criteria cover unmet need, value proposition and differentiation, technical viability, team strength, and business perspective. A scientific description without a user or market case is incomplete, as is a market claim with no feasible validation method.

Application process for the latest guidance

The process below describes how the closed round and the current scheme guidance worked. It is useful preparation, but a future call notice controls.

1. Wait for an announced BIG call. BIRAC says national BIG calls are issued at least twice a year, typically around 1 January and 1 July, but a calendar statement is not an open deadline. The official call notice supplies the actual opening date, closing date, named BIG Partners, and any call-specific instructions.
2. Use the BIRAC online route. Applications must be submitted online through the BIRAC website. Register or sign in, use the proposal format supplied for the call, and complete the required fields and uploads. The system stops accepting applications automatically at the date and time in the call details.
3. Submit a complete proposal early. Provide enough technical detail for a fair review and confirm that files, declarations, ownership information, facility evidence, and budget logic agree with one another. The guidance warns that changes requested after submission are not entertained and that intentionally incorrect information can lead to disqualification.
4. Pass the eligibility check. BIG Partners screen legal and technical eligibility, including scheme fit, project stage, adequate technical detail, and plagiarism concerns. An application can fail before scientific scoring if the company, Project Leader, ownership, facility, or prior-funding position does not meet the rules.
5. Undergo online review. Each eligible proposal is assigned to three to five subject-area reviewers. A review committee then examines the scientific strengths and the reviewer feedback.
6. Present to the Technical Expert Panel. Shortlisted applicants are called for a face-to-face presentation before the centrally conducted Technical Expert Panel. The Project Leader is expected to present the case for support.
7. Complete due diligence if recommended. A recommended applicant is checked by the BIG Partner for financial, technical, legal, resource, compliance, and budget claims. A site visit may be required. Milestones, budget, and payment schedule are finalized at this stage.
8. Accept the offer and execute the project. The guidance allows a maximum of one month to forty-five days to accept the offer and complete due diligence; after 45 days, the offer is treated as withdrawn. Funded teams sign the agreement, report against approved milestones, submit utilization documentation, and participate in monitoring. The guidance also requires BIG grantees to interact with at least two investors during the 18-month project and include the feedback in the final report.

Status of this page and next action

The latest official BIRAC call listing identifies the 25th BIG call as opening on 1 November 2025 and closing at the end of 2025-11-30. The official BIG program page and call index checked for this update do not identify a later BIG round. The page is therefore a historical reference, not a live grant listing. The closed date remains in the front matter so the archive record preserves what happened; historicalReference = true signals that it should not be read as an expired open opportunity.

Applicants should monitor the official BIG program page and the BIRAC call-for-proposals index. When a new call appears, recheck the incorporation-age cutoff, ownership definition, named BIG Partners, proposal format, supporting documents, opening and closing times, and any changes to the funding or review rules. Do not submit against the old call, copy its date into a new plan, or assume that a future window will remain open for the same duration.

Official references

• BIRAC Biotechnology Ignition Grant program page
• BIRAC call-for-proposals index
• BIRAC’s current BIG Scheme Guidelines
• BIRAC’s 25th BIG call listing